Ionis Pharma (IONS) Tops Q4 EPS by 1c

Ionis Pharma (NASDAQ: IONS) reported Q4 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $172.3 million versus the consensus estimate of $124.69 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Vireo Growth completes $20M Pennsylvania dispensary license deal
• Wolfe Research Downgrades Ionis Pharmaceuticals (IONS) to Peerperform